Titre : Dermatoses vasculaires

Dermatoses vasculaires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Avoidance Learning
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Dermatoses vasculaires : Questions médicales les plus fréquentes", "headline": "Dermatoses vasculaires : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Dermatoses vasculaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-11", "dateModified": "2025-03-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Dermatoses vasculaires" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies de la peau", "url": "https://questionsmedicales.fr/mesh/D012871", "about": { "@type": "MedicalCondition", "name": "Maladies de la peau", "code": { "@type": "MedicalCode", "code": "D012871", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Angiomatose bacillaire", "alternateName": "Angiomatosis, Bacillary", "url": "https://questionsmedicales.fr/mesh/D016917", "about": { "@type": "MedicalCondition", "name": "Angiomatose bacillaire", "code": { "@type": "MedicalCode", "code": "D016917", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.060" } } }, { "@type": "MedicalWebPage", "name": "Maladie de Behçet", "alternateName": "Behcet Syndrome", "url": "https://questionsmedicales.fr/mesh/D001528", "about": { "@type": "MedicalCondition", "name": "Maladie de Behçet", "code": { "@type": "MedicalCode", "code": "D001528", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.150" } } }, { "@type": "MedicalWebPage", "name": "Vasculopathie livédoïde", "alternateName": "Livedoid Vasculopathy", "url": "https://questionsmedicales.fr/mesh/D000090122", "about": { "@type": "MedicalCondition", "name": "Vasculopathie livédoïde", "code": { "@type": "MedicalCode", "code": "D000090122", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.406" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Maladie de Raynaud", "alternateName": "Raynaud Disease", "url": "https://questionsmedicales.fr/mesh/D011928", "about": { "@type": "MedicalCondition", "name": "Maladie de Raynaud", "code": { "@type": "MedicalCode", "code": "D011928", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.406.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Papulose atrophiante maligne", "alternateName": "Malignant Atrophic Papulosis", "url": "https://questionsmedicales.fr/mesh/D054853", "about": { "@type": "MedicalCondition", "name": "Papulose atrophiante maligne", "code": { "@type": "MedicalCode", "code": "D054853", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.457" } } }, { "@type": "MedicalWebPage", "name": "Maladie de Kawasaki", "alternateName": "Mucocutaneous Lymph Node Syndrome", "url": "https://questionsmedicales.fr/mesh/D009080", "about": { "@type": "MedicalCondition", "name": "Maladie de Kawasaki", "code": { "@type": "MedicalCode", "code": "D009080", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.560" } } }, { "@type": "MedicalWebPage", "name": "Polyartérite noueuse", "alternateName": "Polyarteritis Nodosa", "url": "https://questionsmedicales.fr/mesh/D010488", "about": { "@type": "MedicalCondition", "name": "Polyartérite noueuse", "code": { "@type": "MedicalCode", "code": "D010488", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.625" } } }, { "@type": "MedicalWebPage", "name": "Syndrome de Sneddon", "alternateName": "Sneddon Syndrome", "url": "https://questionsmedicales.fr/mesh/D018860", "about": { "@type": "MedicalCondition", "name": "Syndrome de Sneddon", "code": { "@type": "MedicalCode", "code": "D018860", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.775" } } }, { "@type": "MedicalWebPage", "name": "Maladie de Takayashu", "alternateName": "Takayasu Arteritis", "url": "https://questionsmedicales.fr/mesh/D013625", "about": { "@type": "MedicalCondition", "name": "Maladie de Takayashu", "code": { "@type": "MedicalCode", "code": "D013625", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Dermatoses vasculaires", "alternateName": "Skin Diseases, Vascular", "code": { "@type": "MedicalCode", "code": "D017445", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Thomas Mentzel", "url": "https://questionsmedicales.fr/author/Thomas%20Mentzel", "affiliation": { "@type": "Organization", "name": "Pathologist, Dermatopathology Department, Dermatopathologie Bodensee, Friedrichshafen, Germany; and." } }, { "@type": "Person", "name": "Martina M Sanchez", "url": "https://questionsmedicales.fr/author/Martina%20M%20Sanchez", "affiliation": { "@type": "Organization", "name": "Departments of Bioengineering, University of California." } }, { "@type": "Person", "name": "Joshua T Morgan", "url": "https://questionsmedicales.fr/author/Joshua%20T%20Morgan", "affiliation": { "@type": "Organization", "name": "Departments of Bioengineering, University of California; jmorgan@engr.ucr.edu." } }, { "@type": "Person", "name": "Hans-Uwe Simon", "url": "https://questionsmedicales.fr/author/Hans-Uwe%20Simon", "affiliation": { "@type": "Organization", "name": "Institute of Pharmacology, University of Bern, Bern, Switzerland." } }, { "@type": "Person", "name": "Dagmar Simon", "url": "https://questionsmedicales.fr/author/Dagmar%20Simon", "affiliation": { "@type": "Organization", "name": "Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. dagmar.simon@insel.ch." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Relation among, trait anxiety, intolerance to uncertainty and early maltreatment experiences on fear discrimination learning and avoidance generalization online task.", "datePublished": "2023-06-05", "url": "https://questionsmedicales.fr/article/37343426", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jbtep.2023.101886" } }, { "@type": "ScholarlyArticle", "name": "Policy abstraction as a predictor of cognitive effort avoidance.", "datePublished": "2023-08-24", "url": "https://questionsmedicales.fr/article/37616076", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1037/xge0001449" } }, { "@type": "ScholarlyArticle", "name": "Safety signals reinforce instrumental avoidance in humans.", "datePublished": "2024-09-11", "url": "https://questionsmedicales.fr/article/39260876", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1101/lm.053914.123" } }, { "@type": "ScholarlyArticle", "name": "Foster children avoidance-related interactive behaviors with caregivers.", "datePublished": "2022-11-25", "url": "https://questionsmedicales.fr/article/36442420", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.chiabu.2022.105973" } }, { "@type": "ScholarlyArticle", "name": "A network perspective on real-life threat, anxiety, and avoidance.", "datePublished": "2023-08-02", "url": "https://questionsmedicales.fr/article/37531080", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jclp.23575" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de la peau et du tissu conjonctif", "item": "https://questionsmedicales.fr/mesh/D017437" }, { "@type": "ListItem", "position": 3, "name": "Maladies de la peau", "item": "https://questionsmedicales.fr/mesh/D012871" }, { "@type": "ListItem", "position": 4, "name": "Dermatoses vasculaires", "item": "https://questionsmedicales.fr/mesh/D017445" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Dermatoses vasculaires - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Dermatoses vasculaires", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Dermatoses vasculaires", "description": "Comment diagnostique-t-on une dermatoses vasculaire ?\nQuels tests sont utilisés pour évaluer les dermatoses vasculaires ?\nLes dermatoses vasculaires nécessitent-elles des examens sanguins ?\nQuels signes cliniques indiquent une dermatoses vasculaire ?\nPeut-on confondre les dermatoses vasculaires avec d'autres maladies ?", "url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Avoidance+Learning&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Dermatoses vasculaires", "description": "Quels sont les symptômes courants des dermatoses vasculaires ?\nLes dermatoses vasculaires provoquent-elles des douleurs ?\nLes dermatoses vasculaires peuvent-elles causer des saignements ?\nY a-t-il des symptômes systémiques associés ?\nLes démangeaisons sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Avoidance+Learning&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Dermatoses vasculaires", "description": "Comment prévenir les dermatoses vasculaires ?\nL'hydratation de la peau est-elle importante ?\nLes vêtements peuvent-ils aider à prévenir ces affections ?\nFaut-il éviter certains aliments ?\nLe stress influence-t-il les dermatoses vasculaires ?", "url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Avoidance+Learning&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Dermatoses vasculaires", "description": "Quels traitements sont disponibles pour les dermatoses vasculaires ?\nLes corticostéroïdes sont-ils efficaces ?\nQuand faut-il envisager une intervention chirurgicale ?\nLes traitements naturels sont-ils recommandés ?\nLes lasers sont-ils efficaces pour traiter ces affections ?", "url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Avoidance+Learning&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Dermatoses vasculaires", "description": "Quelles complications peuvent survenir ?\nLes dermatoses vasculaires peuvent-elles affecter la qualité de vie ?\nY a-t-il un risque de cancer associé ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Avoidance+Learning&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Dermatoses vasculaires", "description": "Quels sont les principaux facteurs de risque ?\nLe tabagisme est-il un facteur de risque ?\nL'exposition au soleil influence-t-elle ces affections ?\nLe stress est-il un facteur de risque ?\nLes maladies chroniques augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Avoidance+Learning&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une dermatoses vasculaire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et parfois des biopsies cutanées." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les dermatoses vasculaires ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'échographie Doppler et l'angiographie peuvent être utilisés." } }, { "@type": "Question", "name": "Les dermatoses vasculaires nécessitent-elles des examens sanguins ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des examens sanguins peuvent être réalisés pour évaluer des troubles sous-jacents." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une dermatoses vasculaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des rougeurs, des ecchymoses ou des lésions vasculaires visibles peuvent indiquer une affection." } }, { "@type": "Question", "name": "Peut-on confondre les dermatoses vasculaires avec d'autres maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être confondues avec des maladies comme le psoriasis ou l'eczéma." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des dermatoses vasculaires ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des rougeurs, des démangeaisons, et des lésions cutanées." } }, { "@type": "Question", "name": "Les dermatoses vasculaires provoquent-elles des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent provoquer des douleurs, surtout si les lésions sont enflammées." } }, { "@type": "Question", "name": "Les dermatoses vasculaires peuvent-elles causer des saignements ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines peuvent entraîner des saignements, notamment les télangiectasies." } }, { "@type": "Question", "name": "Y a-t-il des symptômes systémiques associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fièvre ou la fatigue peuvent survenir dans certains cas." } }, { "@type": "Question", "name": "Les démangeaisons sont-elles fréquentes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les démangeaisons sont un symptôme fréquent des dermatoses vasculaires." } }, { "@type": "Question", "name": "Comment prévenir les dermatoses vasculaires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les facteurs de risque comme l'exposition au soleil et le tabagisme peut aider." } }, { "@type": "Question", "name": "L'hydratation de la peau est-elle importante ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir la peau hydratée peut réduire le risque d'irritation et de lésions." } }, { "@type": "Question", "name": "Les vêtements peuvent-ils aider à prévenir ces affections ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, porter des vêtements protecteurs peut réduire l'exposition aux irritants." } }, { "@type": "Question", "name": "Faut-il éviter certains aliments ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certaines personnes peuvent bénéficier d'un régime anti-inflammatoire pour réduire les symptômes." } }, { "@type": "Question", "name": "Le stress influence-t-il les dermatoses vasculaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut aggraver les symptômes, donc des techniques de gestion du stress sont utiles." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les dermatoses vasculaires ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des crèmes topiques, des lasers et parfois des médicaments oraux." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les corticostéroïdes peuvent réduire l'inflammation et les symptômes cutanés." } }, { "@type": "Question", "name": "Quand faut-il envisager une intervention chirurgicale ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une intervention chirurgicale est envisagée pour les cas graves ou réfractaires aux traitements." } }, { "@type": "Question", "name": "Les traitements naturels sont-ils recommandés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains traitements naturels peuvent aider, mais il est important de consulter un médecin." } }, { "@type": "Question", "name": "Les lasers sont-ils efficaces pour traiter ces affections ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les lasers peuvent réduire l'apparence des lésions vasculaires et améliorer l'esthétique." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des infections ou des cicatrices peuvent survenir si non traitées." } }, { "@type": "Question", "name": "Les dermatoses vasculaires peuvent-elles affecter la qualité de vie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des problèmes psychologiques et affecter l'estime de soi." } }, { "@type": "Question", "name": "Y a-t-il un risque de cancer associé ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines dermatoses vasculaires peuvent avoir un risque accru de cancer cutané." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications ne sont pas fréquentes mais peuvent survenir dans des cas graves." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite souvent une approche multidisciplinaire et un suivi régulier." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le sexe féminin, et des antécédents familiaux de dermatoses." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut aggraver les dermatoses vasculaires et augmenter les symptômes." } }, { "@type": "Question", "name": "L'exposition au soleil influence-t-elle ces affections ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition excessive au soleil peut aggraver les dermatoses vasculaires." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut exacerber les symptômes et augmenter le risque de dermatoses." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies chroniques, comme le diabète, peuvent augmenter le risque de dermatoses." } } ] } ] }

Sources (10000 au total)

Relation among, trait anxiety, intolerance to uncertainty and early maltreatment experiences on fear discrimination learning and avoidance generalization online task.

Early aversive experiences, which have been associated with elevated anxiety and intolerance of uncertainty (IUS), may contribute negatively to fear conditioning learning. The aim of the present study... We adapted an avoidance procedure in an online fear learning task. Two pictures of different lamp colors (CS+) were first associated with two aversive images (US), while a third color was not (CS-). N... Aversive early experiences were positively related to trait anxiety and intolerance of uncertainty. The results of the task further suggested that maltreatment experience contributes to be more attent... Online experiments implies some loss of control over subjects and environment that can threaten internal validity. Likewise, the commitment of participants may be low.... Results suggest that early aversive experience and anxiety could contribute to the development of IUS, which likely contributes to the development of avoidance behavior....

Foster children avoidance-related interactive behaviors with caregivers.

A lot of the research concerning foster children - often children who have suffered maltreatment in the family home - has focused on internalized and externalized symptoms. Few studies, however, have ... The purpose of this study is to explore the Emotion Regulation Strategies (ERS) of children in foster care and to highlight those most commonly employed in family or placement contexts. The parents' a... An in-depth analysis of observation sequences was performed. Three data collection times, spaced across a period of 6 months (t1, t2 and t3), were included in the observation protocol. Each observatio... Children tended to be readily distracted when interacting with adults, and more particularly so with their parents. While they tended to display relatively normative processes with a foster carer, the... This study highlights the prevalence of distraction behavior in foster children during their interactions with caregivers, and offers an insight into how structured interactions provide a framework th...

A network perspective on real-life threat, anxiety, and avoidance.

Anxiety, approach, and avoidance motivation crucially influence mental and physical health, especially when environments are stressful. The interplay between anxiety and behavioral motivation is modul... A total of 436 participants who were matched on age and gender (218 psychotherapy patients, 218 online-recruited nonpatients) completed an online survey assessing these factors in response to the COVI... The resulting cross-sectional psychological network revealed a complex pattern with multiple positive (e.g., between trait anxiety, avoidance motivation, and avoidance behavior) and negative associati...

Avoidance behaviour modulates but does not condition phonophobia in migraine.

Past studies do not account for avoidance behaviour in migraine as a potential confounder of phonophobia.... To analyse whether phonophobia is partially driven by avoidance behaviour when using the classic methodology (method of limits).... This is a case-control study where we tested phonophobia in a cohort of high-frequency/chronic migraine patients (15.5 ± 0.74 headache days/month) and non-headache controls. Auditory stimuli, delivere... In this study, we successfully replicate previously reported reduction in sound aversion threshold using three different methods in a group of 35 patients and 25 controls (p < 0.0001). Avoidance be... Avoidance behaviour can exacerbate phonophobia. The current methodology to measure phonophobia needs to be revised....

More engagement in inefficient avoidance through partial reinforcement.

In anxiety-related disorders, excessive avoidance often coexists with an impaired sense of control over external threats. In contrast, lab studies have shown that avoidance responding increase with hi... We conducted an experiment that additionally included a completely uncontrollable threat, and we manipulated the reinforcement rate of the avoidance response to the (semi-)controllable threat (75% ver... The 100% group showed increased avoidance to the controllable threat and decreased avoidance to the unavoidable threat over learning. Interestingly, compared to the 100% group, the 75% group displayed... Only two reinforcement rates of effective avoidance were included, which may limit the generalizability of the current findings. Perceived control was not directly measured.... Lower reinforcement rates create ambiguity between effective and ineffective situations of avoidance, which engenders generalization of unpredictability from effective to ineffective situation, thereb...

An experimental test of the effects of acute sleep deprivation on affect and avoidance.

Avoidance and sleep have been identified as mechanisms involved in the development and maintenance of many mental health disorders. However, there has been little research into the relation between sl... To address this, a randomized controlled experiment using behavioral and self-report measures of affect and avoidance was conducted. Compared to a control group, we hypothesized that sleep-deprived in... Repeated measures ANOVAs demonstrated negative affectivity and self-reported avoidance increased, and positive affectivity decreased, from pre-to post-manipulation in the sleep loss condition as expec... This study emphasized internal validity over generalizability. Additionally, the at-home sleep deprivation limited researcher control over the overnight activities of participants.... Results replicate prior work on the affective consequences of sleep deprivation and highlight a discrepancy between the effect of sleep deprivation on behavioral avoidance toward a specific stimulus c...